Analysis of interleukin (IL)-8 expression in human astrocytomas: Associations with IL-6, cyclooxygenase-2, vascular endothelial growth factor, and microvessel morphometry

Human Immunology

Volumn 70, Issue 6, 2009, Pages 391-397

  Samaras, Vassilis ^a   Piperi, Christina ^a   Levidou, Georgia ^a   Zisakis, Athanasios ^a   Kavantzas, Nikolaos ^a   Themistocleous, Marios S ^a   Boviatsis, Efstathios I ^a   Barbatis, Calypso ^a   Lea, Robert W ^b   Kalofoutis, Anastasios ^a   Korkolopoulou, Penelope ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

Astrocytomas; COX 2; IL 6; IL 8; VEGF

Indexed keywords

CD31 ANTIGEN; CD34 ANTIGEN; CYCLOOXYGENASE 2; INTERLEUKIN 6; INTERLEUKIN 8; VASCULOTROPIN;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER GRADING; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GLIOBLASTOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROVASCULATURE; MORPHOMETRICS; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR NECROSIS; TUMOR VASCULARIZATION;

ADULT; AGED; ANTIGENS, CD34; ASTROCYTOMA; BRAIN NEOPLASMS; CYCLOOXYGENASE 2; FEMALE; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; MALE; MICROVESSELS; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; VASCULAR ENDOTHELIAL GROWTH FACTOR A; YOUNG ADULT;

EID: 67349149657     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2009.03.011     Document Type: Article

References (39)

1. Hsieh J.C., and Lesniak M.S. Surgical management of high-grade gliomas. Expert Rev Neurother 5 (2005) 33-39
2. Maher E.A., Furnari F.B., Bachoo R.M., Rowitch D.H., Louis D.N., Cavenee W.K., et al. Malignant glioma: genetics and biology of a grave matter. Genes Dev 15 (2001) 1311-1333
3. Cavenee W.K., Nagane M., Huang H.-J.S., Newcomb E.W., Bigner D.D., Weller M., et al. FF. International Agency for Research on Cancer. Pathology and genetics of tumours of the nervous system (2000), IARC Press, Lyon 10-21
4. Burger P.C., and Green S.B. Patient age, histologic features, and length of survival in patients with glioblastoma multiforme. Cancer 59 (1987) 1617-1625
5. Korkolopoulou P., Patsouris E., Konstantinidou A.E., Pavlopoulos P.M., Kavantzas N., Boviatsis E., et al. Hypoxia-inducible factor 1α/vascular endothelial growth factor axis in astrocytomas. Associations with microvessel morphometry, proliferation and prognosis. Neuropathol Appl Neurobiol 30 (2004) 267-278
6. Wenger R.H., and Gassmann M. Oxygen(es) and the hypoxia-inducible factor-1. Biol Chem 378 (1997) 609-616
7. Zhong H., Chiles K., Feldser D., Laughner E., Hanrahan C., Georgescu M.M., et al. Modulation of hypoxia-inducible factor 1alpha expression by the epidermal growth factor/phosphatidylinositol 3-kinase/PTEN/AKT/FRAP pathway in human prostate cancer cells: implications for tumor angiogenesis and therapeutics. Cancer Res 60 (2000) 1541-1545
8. Dubois R.N., Awad J., Morrow J., Roberts L.J., and Bishop P.R. Regulation of eicosanoid production and mitogenesis in rat intestinal epithelial cells by transforming growth factor-alpha and phorbol ester. J Clin Invest 93 (1994) 493-498
9. Perdiki M., Korkolopoulou P., Thymara I., Agrogiannis G., Piperi C., Boviatsis E., et al. Cyclooxygenase-2 expression in astrocytomas. Relationship with microvascular parameters, angiogenic factors expression and survival. Mol Cell Biochem 295 (2007) 75-83
10. Hao C., Parney I.F., Roa W.H., Turner J., Petruk K.C., and Ramsay D.A. Cytokine and cytokine receptor mRNA expression in human glioblastomas: evidence of Th1, Th2 and Th3 cytokine dysregulation. Acta Neuropathol (Berl) 103 (2002) 171-178
11. Schneider J., Hofman F.M., Apuzzo M.L., and Hinton D.R. Cytokines and immunoregulatory molecules in malignant glial neoplasms. J Neurosurg 77 (1992) 265-273
12. Rolhion C., Penault-Llorca F., Kemeny J.L., Lemaire J.J., Jullien C., Labit-Bouvier C., et al. Interleukin-6 overexpression as a marker of malignancy in human gliomas. J Neurosurg 94 (2001) 97-101
13. Chang C.Y., Li M.C., Liao S.L., Huang Y.L., Shen C.C., and Pan H.C. Prognostic and clinical implication of IL-6 expression in glioblastoma multiforme. J Clin Neurosci 12 (2005) 930-933
14. Aloisi F., Gare A., Borsellino G., Gallo P., Rosa S., Bassani A., et al. Production of hemolymphopoietic cytokines (IL-6, IL-8, colony-stimulating factors) by normal human astrocytes in response to IL-1 beta and tumour necrosis factor-alpha. J Immunol 149 (1992) 2358-2366
15. Tchirkov A., Rolhion C., Bertrand S., Dore J.F., Dubost J.J., and Verrelle P. IL-6 gene amplification and expression in human glioblastomas. Br J Cancer 85 (2001) 518-522
16. Samaras V., Piperi C., Korkolopoulou P., Zisakis A., Levidou G., Themistocleous M.S., et al. Application of the ELISPOT method for comparative analysis of interleukin (IL)-6 and IL-10 secretion in peripheral blood of patients with astroglial tumours. Mol Cell Biochem 304 (2007) 343-351
17. Zisakis A., Piperi C., Themistocleous M.S., Korkolopoulou P., Boviatsis E.I., Sakas D.E., et al. Comparative analysis of peripheral and localised cytokine secretion in glioblastoma patients. Cytokine 39 (2007) 99-105
18. Baggiolini M., Walz A., and Kunkel S.L. Neutrophil-activating peptide-1/interleukin 8, a novel cytokine that activates neutrophils. J Clin Invest 84 (1989) 1045-1049
19. Rossi D., and Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 18 (2000) 217-242
20. Brat D.J., Bellail A.C., and Van Meir E.G. The role of interleukin-8 and its receptors in gliomagenesis and tumoural angiogenesis. Neuro-oncol 7 (2005) 122-133
21. Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev 12 (2001) 375-391
22. Hu D.E., Hori Y., and Fan T.P. Interleukin-8 stimulates angiogenesis in rats. Inflammation 17 (1993) 135-143
23. Koch A.E., Polverini P.J., Kunkel S.L., Harlow L.A., DiPietro L.A., Elner V.M., et al. Interleukin-8 as a macrophage derived mediator of angiogenesis. Science 258 (1992) 1798-1801
24. Strieter R.M., Kunkel S.L., Elner V.M., Martonyi C.L., Koch A.E., Polverini P.J., et al. Interleukin-8. A corneal factor that induces neovascularization. Am J Pathol 141 (1992) 1279-1284
25. Louis D.N., Ohgaki H., Wiestler O.D., Cavenee W.K., Burger P.C., Jouvet A., et al. The 2007 WHO Classification of Tumours of the Central Nervous System. Acta Neuropathol (Berl) 114 (2007) 97-109
26. Czerkinsky C., Moldoveanu Z., and Mestecky J. A novel two color ELISPOT assay. I. Similtaneous detection of distinct types of antibody-secreting cells. J Immunol Methods 115 (1988) 31-37
27. McCutcheon M., Wehner N., and Wensky A. A sensitive ELISPOT assay to detect low-frequency human T-lymphocytes. J Immunol Methods 210 (1997) 149-166
28. Mashishi T., and Gray C.M. The ELISPOT assay: an easily transferable method for measuring cellular responses and identifying T cell epitopes. Clin Chem Lab Med 40 (2002) 903-910
29. Tada M., Diserens A.C., Desbaillets I., and de Tribolet N. Analysis of cytokine receptor messenger RNA expression in human glioblastoma cells and normal astrocytes by reverse-transcription polymerase chain reaction. J Neurosurg 80 (1994) 1063-1073
30. Van Meir E.G., Ceska M., Effenberger F., Walz A., Grouzmann E., Desbaillets I., et al. Interleukin-8 is produced in neoplastic and infectious diseases of the human central nervous system. Cancer Res 52 (1992) 4297-4305
31. Desbaillets I., Diserens A.C., Tribolet N., Hamou M.F., and Van Meir E.G. Upregulation of interleukin 8 by oxygen-deprived cells in glioblastoma suggests a role in leukocyte activation, chemotaxis, and angiogenesis. J Exp Med 186 (1997) 1201-1212
32. Garkavtsev I., Kozin S.V., Chernova O., Xu L., Winkler F., Brown E., et al. The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis. Nature 428 (2004) 328-332
33. Nitta T., Steinman L., and Sato K. An analysis of lymphokine gene expression within astrocytoma. No Shinkei Geka 20 (1992) 763-768
34. Naldini A., Carraro F., and Silvestri S. Hypoxia affects cytokine production and proliferative responses by human peripheral mononuclear cells. J Cell Physiol 173 (1997) 335-342
35. Loeffler S., Fayard B., Weis J., and Weissenberger J. Interleukin-6 induces transcriptional activation of vascular endothelial growth factor (VEGF) in astrocytes in vivo and regulates VEGF promoter activity in glioblastoma cells via direct interaction between STAT3 and Sp1. Int J Cancer 115 (2005) 202-213
36. Li V.W., Folkerth R.D., and Watanabe H. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumours. Lancet 344 (1994) 82-86
37. Fosslien E. Escape from immunological surveillance in blastocyst implantation and cancer. Ann Clin Lab Sci 30 (2000) 111-112
38. Joki T., Heese O., Nikas D.C., Bello L., Zhang J., Kraeft S.K., et al. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398. Cancer Res 60 (2000) 4926-4931
39. Shono T., Tofilon P.J., Bruner J.M., Owolabi O., and Lang F.F. Cyclooxygenase-2 expression in human gliomas: prognostic significance and molecular correlations. Cancer Res 61 (2001) 4375-4381